IDH1 and central nervous system cancer: Univariate and multivariate Cox regression demonstrated that this interaction stood as an independent prognostic predictor of survival.<h4>Conclusion</h4>Our results suggest infrequent instances of exceptional responses ascribable to tumor genomics yet corroborate the existence of an interaction of temozolomide with IDH1 mutations in lower-grade glioma.